Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 17 | 2022 | 776 | 1.270 |
Why?
|
| Neuropsychological Tests | 14 | 2022 | 1176 | 0.610 |
Why?
|
| Cognition Disorders | 8 | 2018 | 965 | 0.540 |
Why?
|
| Glucosylceramidase | 4 | 2022 | 17 | 0.510 |
Why?
|
| Subthalamic Nucleus | 2 | 2022 | 17 | 0.410 |
Why?
|
| Deep Brain Stimulation | 2 | 2022 | 35 | 0.390 |
Why?
|
| Tourette Syndrome | 1 | 2009 | 11 | 0.330 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2018 | 119 | 0.260 |
Why?
|
| Cognition | 4 | 2022 | 1265 | 0.240 |
Why?
|
| Dementia | 4 | 2016 | 532 | 0.240 |
Why?
|
| Quality of Life | 1 | 2009 | 600 | 0.230 |
Why?
|
| Executive Function | 4 | 2018 | 98 | 0.220 |
Why?
|
| Mutation | 4 | 2022 | 325 | 0.220 |
Why?
|
| Male | 21 | 2022 | 13917 | 0.220 |
Why?
|
| Phonation | 1 | 2003 | 6 | 0.220 |
Why?
|
| Female | 21 | 2022 | 14273 | 0.220 |
Why?
|
| Speech Disorders | 1 | 2003 | 11 | 0.220 |
Why?
|
| Middle Aged | 17 | 2022 | 8403 | 0.210 |
Why?
|
| Electric Stimulation | 1 | 2003 | 46 | 0.210 |
Why?
|
| Speech | 1 | 2003 | 22 | 0.210 |
Why?
|
| Respiration | 1 | 2003 | 32 | 0.210 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2012 | 305 | 0.200 |
Why?
|
| Aged | 17 | 2022 | 8501 | 0.200 |
Why?
|
| Severity of Illness Index | 7 | 2017 | 913 | 0.200 |
Why?
|
| Heterozygote | 1 | 2022 | 91 | 0.190 |
Why?
|
| Cognitive Dysfunction | 4 | 2016 | 1017 | 0.190 |
Why?
|
| Hallucinations | 2 | 2014 | 61 | 0.170 |
Why?
|
| Humans | 22 | 2022 | 25692 | 0.170 |
Why?
|
| Movement Disorders | 2 | 2013 | 82 | 0.160 |
Why?
|
| Disease Progression | 3 | 2016 | 664 | 0.150 |
Why?
|
| Ataxia | 1 | 2018 | 78 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2018 | 103 | 0.140 |
Why?
|
| Tremor | 1 | 2018 | 114 | 0.140 |
Why?
|
| Corpus Callosum | 1 | 2017 | 11 | 0.140 |
Why?
|
| Fragile X Syndrome | 1 | 2018 | 186 | 0.130 |
Why?
|
| Postural Balance | 1 | 2016 | 113 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 1084 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 259 | 0.120 |
Why?
|
| Memory Disorders | 2 | 2014 | 160 | 0.120 |
Why?
|
| Psychotherapy, Psychodynamic | 1 | 2013 | 1 | 0.110 |
Why?
|
| Psychotherapy, Brief | 1 | 2013 | 2 | 0.110 |
Why?
|
| Nerve Net | 1 | 2014 | 31 | 0.110 |
Why?
|
| Somatoform Disorders | 1 | 2013 | 14 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2014 | 138 | 0.110 |
Why?
|
| Psychometrics | 1 | 2013 | 216 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 155 | 0.100 |
Why?
|
| Entorhinal Cortex | 1 | 2012 | 36 | 0.100 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 111 | 0.100 |
Why?
|
| Atrophy | 3 | 2017 | 88 | 0.090 |
Why?
|
| Sleep | 1 | 2013 | 316 | 0.090 |
Why?
|
| Huntington Disease | 1 | 2010 | 43 | 0.080 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 16 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 119 | 0.080 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 35 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2016 | 392 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 4459 | 0.080 |
Why?
|
| Attention | 3 | 2014 | 133 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 847 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2009 | 640 | 0.070 |
Why?
|
| Psychophysiologic Disorders | 1 | 2005 | 6 | 0.060 |
Why?
|
| Adolescent | 2 | 2009 | 2076 | 0.060 |
Why?
|
| Adult | 5 | 2015 | 7336 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2005 | 38 | 0.060 |
Why?
|
| Child | 1 | 2009 | 1277 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2017 | 532 | 0.060 |
Why?
|
| Speech Articulation Tests | 1 | 2003 | 3 | 0.050 |
Why?
|
| Acoustics | 1 | 2003 | 18 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2003 | 42 | 0.050 |
Why?
|
| Mental Status Schedule | 2 | 2015 | 96 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 472 | 0.050 |
Why?
|
| Memory | 2 | 2013 | 296 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 329 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1781 | 0.040 |
Why?
|
| Walking Speed | 1 | 2018 | 40 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2018 | 3220 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 54 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 163 | 0.030 |
Why?
|
| Depression | 2 | 2012 | 412 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 625 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 82 | 0.030 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Space Perception | 1 | 2014 | 24 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 71 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 326 | 0.030 |
Why?
|
| Language | 1 | 2014 | 65 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 63 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2013 | 24 | 0.030 |
Why?
|
| Gait | 1 | 2016 | 350 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1300 | 0.030 |
Why?
|
| Amnesia | 1 | 2012 | 25 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 103 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 255 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 126 | 0.020 |
Why?
|
| Checklist | 1 | 2011 | 30 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 277 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 443 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 262 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 646 | 0.020 |
Why?
|
| United States | 1 | 2015 | 1943 | 0.020 |
Why?
|
| Mass Screening | 1 | 2010 | 168 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2010 | 252 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 560 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2005 | 36 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2005 | 104 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 84 | 0.020 |
Why?
|
| Anxiety | 1 | 2005 | 150 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 1336 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 1689 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 3231 | 0.010 |
Why?
|